Abstract:[Objective]Human coagulation factor Ⅸ (hFIX) plays a key role in blood coagulation and is important for clinical treatment of hemophilia. The objective of this study is to construct human coagulation factor Ⅸ (hFIX) mammary expression vector and test the expression of hFIX in porcine mammary epithelial, and obtain hFIX-transgenic porcine mammary epithelial and female porcine fetal fibroblast cells to prepare to produce hFIX mammary specific expression transgenic pigs .[Method]Total RNA was extracted from human fetal liver tissues and human coagulation factor Ⅸ (hFIX) cDNA was amplified by RT-PCR followed the instructions of RNAiso Reagent and Prime Script RT-PCR Kit from TAKARA. PCR was performed to amplify bovine growth hormone (BGH) polyA fragment. Both hFIX cDNA and BGH polyA fragments were cloned to pbCSN2-RC plasmid, located after the bovine beta-Casein (CSN2) promoter, to achieve mammary specific expression vector pbCSN2-hFIX-pA-RC with neomycin-resistance and red fluorescence genes. Porcine mammary epithelial cells were obtained by culturing 1mm3 mammary tissue cubes from the breast tissue of lactation pigs that slaughtered in the local slaughterhouse and purifying with time-controlled trypsinization. The chromosome analysis was performed on the derived cells, and the cells with normal number of chromosomes were transfected with pbCSN2-hFIX-pA-RC by lipofection technology. The transfected porcine mammary epithelial cells were screened by neomycin-resistance and red fluorescent expression. The expression of hFIX was further confirmed by real-time PCR. To only transfect the female fibroblasts, the SRY PCR was performed on the porcine fibroblasts cultured in the lab to determine the sex of the cells. Finally, the confirmed vector was transferred to porcine fetal fibroblast cells by lipofection technology. [Result] The results of PCR and restricted endonucleases digestion analysis showed that the hFIX cDNA and BGH PolyA were cloned into pbCSN2-RC, and the pbCSN2-hFIX-pA-RC with double screening labels was successfully constructed. After screening by G418 and red fluorescent expression of transfected porcine mammary epithelial cells, the expression of hFIX directed by bovineβ-casein in porcine mammary epithelial cells was confirmed by real-time PCR in the positive cells. This result indicated that the vector pbCSN2-hFIX-pA-RC has the ability to direct the hFIX mammary specific expression. Then the constructed vector was transferred into female porcine fetal fibroblasts. After screening, the positive hFIX-transgenic female porcine fetal fibroblast cells were obtained successfully.[Conclusion]The bovineβ-casein promoter can successfully direct the mammary specific expression of exogenous gene. This research has laid a massive foundation for cultivating mammary gland bioreactor by somatic cell nuclear transfer.

Comparison of Human Coagulation Factor VIII Expression Directed by Cytomegalovirus and Mammary Gland-Specific Promoters in HC11 Cells and Transgenic Mice.

Sustaining Expression of B Domain-Deleted Human Factor VIII Mediated by Using Lentiviral Vectors in NOD/SCID Mouse.

Expression of Biologically Active Human Clotting Factor IX (hf IX) in the Mammary Gland of Transgenic Mice

Efficient Stabilization of Recombinant Human Coagulation Factor VIII in the Milk of Transgenic Mice Using Hfviii and Vwf Co-Expression Vector Transduction

[In Vivo Transfection and Expression of Human Coagulant Factor VIII Cdna in Mice].

Sperm mediated human coagulation factor VIII gene transfer and expression in transgenic mice.

High Level Expression of Human Factor VIII in Mammalian Cells after Retroviral-Mediated Gene Transfer.

The Expression of Recombinant Human Serum Albumin in the Mammary Gland of Transgenic Mice

[Sperm-Mediated Expression of Human Clotting Factor VIII Gene in Transgenic Offspring of Mice].

[Non-Viral Vector Mediating Human Coagulation Factor VIII Gene Expression in Mouse 32D Cell Line].

The Gene Expression of Coagulation Factor VIII in Mammalian Cell Lines.

Construction of Human CoaguLation Factor Ⅸ Mammary Expression Vector and Transfection

Expression of a Recombinant Anti-Programed Cell Death 1 Antibody in the Mammary Gland of Transgenic Mice

Evaluation of the Activity Levels of Rat FVIII and Human FVIII Delivered by Adeno-Associated Viral Vectors Both in Vitro and in Vivo.

Enhanced factor VIII heavy chain for gene therapy of hemophilia A.

A high efficient FVIII variant corrects bleeding in hemophilia A mouse model

Transgenic Mice Can Express Mutant Human Coagulation Factor IX with Higher Level of Clotting Activity

CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice.

857. Molecular Engineering of Factor VIII for Raav Delivery

Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.

Construction Of A Novel Lentiviral Vector Carrying Human B-Domain-Deleted Factor Viii Gene